Gadolinium-based hybrid nanoparticles as a positive MR contrast agent

被引:207
作者
Hifumi, Hiroki
Yamaoka, Seiichi
Tanimoto, Akihiro
Citterio, Daniel
Suzuki, Koji
机构
[1] Keio Univ, Fac Sci & Technol, Dept Appl Chem, Kohoku Ku, Yokohama, Kanagawa 2238522, Japan
[2] Keio Univ, Sch Med, Dept Diagnost Radiol, Kohoku Ku, Yokohama, Kanagawa 2238522, Japan
[3] JST Agcy, CREST, Kawaguchi, Saitama 3320012, Japan
关键词
D O I
10.1021/ja066442d
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
A new nanoparticulate inorganic-organic hybrid-type positive contrast agent (CA), PGP/dextran-K01, was synthesized based on a GdPO4 inorganic core as a relaxation-time-shortening moiety and a dextran-coating, which generates monodispersibility in water, a high relaxation-time-shortening effect by retaining a large number of water molecules in proximity of the core and toxicity reduction in in-vivo studies. This PGP/dextran-K01 nanoparticle has high r1 and r2 values and a significantly low r2/r1 value, 1.1, which is unprecedented and which is the lowest value among existing nanoparticulate CAs indicating that PGP/dextran-K01 is a positive contrast agent. Because of this low r2/r1 value and the nanoparticulate shape, PGP/dextran-K01 will be a useful clinical substitute for negative CAs based on iron oxides. Copyright © 2006 American Chemical Society.
引用
收藏
页码:15090 / 15091
页数:2
相关论文
共 36 条
[1]   Gadolinium(III) chelates as MRI contrast agents: Structure, dynamics, and applications [J].
Caravan, P ;
Ellison, JJ ;
McMurry, TJ ;
Lauffer, RB .
CHEMICAL REVIEWS, 1999, 99 (09) :2293-2352
[2]   Stability and instability: Two faces of coronary atherosclerosis - The Paul Dudley White Lecture 1995 [J].
Davies, MJ .
CIRCULATION, 1996, 94 (08) :2013-2020
[3]   Water-soluble GdF3 and GdF3/LaF3 nanoparticles-physical characterization and NMR relaxation properties [J].
Evanics, F. ;
Diamente, P. R. ;
van Veggel, F. C. J. M. ;
Stanisz, G. J. ;
Prosser, R. S. .
CHEMISTRY OF MATERIALS, 2006, 18 (10) :2499-2505
[4]   IRON-OXIDES AS MR IMAGING CONTRAST AGENTS [J].
FAHLVIK, AK ;
KLAVENESS, J ;
STARK, DD .
JMRI-JOURNAL OF MAGNETIC RESONANCE IMAGING, 1993, 3 (01) :187-194
[5]   CORONARY PLAQUE DISRUPTION [J].
FALK, E ;
SHAH, PK ;
FUSTER, V .
CIRCULATION, 1995, 92 (03) :657-671
[6]  
GROMAN EV, 1989, Patent No. 4827945
[7]   CLINICAL-APPLICATION OF SUPERPARAMAGNETIC IRON-OXIDE TO MR IMAGING OF TISSUE PERFUSION IN VASCULAR LIVER-TUMORS [J].
HAHN, PF ;
STARK, DD ;
WEISSLEDER, R ;
ELIZONDO, G ;
SAINI, S ;
FERRUCCI, JT .
RADIOLOGY, 1990, 174 (02) :361-366
[8]   CONTRAST-ENHANCED MR-IMAGING OF LIVER AND SPLEEN - 1ST EXPERIENCE IN HUMANS WITH A NEW SUPERPARAMAGNETIC IRON-OXIDE [J].
HAMM, B ;
STAKS, T ;
TAPUITZ, M ;
MAIBAUER, R ;
SPEIDEL, A ;
HUPPERTZ, A ;
FRENZEL, T ;
LAWACZECK, R ;
WOLF, KJ ;
LANGE, L .
JMRI-JOURNAL OF MAGNETIC RESONANCE IMAGING, 1994, 4 (05) :659-668
[9]   Macromolecular intravenous contrast agent for MR lymphography: Characterization and efficacy studies [J].
Harika, L ;
Weissleder, R ;
Poss, K ;
Papisov, MI .
RADIOLOGY, 1996, 198 (02) :365-370
[10]   MR LYMPHOGRAPHY WITH A LYMPHOTROPIC T-1-TYPE MR CONTRAST AGENT - GD-DTPA-PGM [J].
HARIKA, L ;
WEISSLEDER, R ;
POSS, K ;
ZIMMER, C ;
PAPISOV, MI ;
BRADY, TJ .
MAGNETIC RESONANCE IN MEDICINE, 1995, 33 (01) :88-92